These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15829128)

  • 1. Testosterone replacement-induced hyperprolactinaemia: case report and review of the literature.
    Sodi R; Fikri R; Diver M; Ranganath L; Vora J
    Ann Clin Biochem; 2005 Mar; 42(Pt 2):153-9. PubMed ID: 15829128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up.
    Berinder K; Stackenäs I; Akre O; Hirschberg AL; Hulting AL
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):450-5. PubMed ID: 16181238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma.
    Gillam MP; Middler S; Freed DJ; Molitch ME
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4447-51. PubMed ID: 12364416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
    Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of pituitary magnetic resonance imaging in men with hypogonadism.
    Rhoden EL; Estrada C; Levine L; Morgentaler A
    J Urol; 2003 Sep; 170(3):795-8. PubMed ID: 12913700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone-related exacerbation of a prolactin-producing macroadenoma: possible role for estrogen.
    Prior JC; Cox TA; Fairholm D; Kostashuk E; Nugent R
    J Clin Endocrinol Metab; 1987 Feb; 64(2):391-4. PubMed ID: 3793856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia.
    Le Moli R; Endert E; Fliers E; Prummel MF; Wiersinga WM
    Neth J Med; 2003 Feb; 61(2):44-8. PubMed ID: 12735420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypogonadism secondary to hyperprolactinaemia: successful treatment but adverse consequences.
    Narayanan RP; Bujawansa S; Qureshi Z; Rimmer M; Heald A
    Exp Clin Endocrinol Diabetes; 2012 May; 120(5):311-3. PubMed ID: 22441722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidentally discovered pituitary macroadenoma. Neurosurgical treatment indications illustrated by two cases].
    Maciá-Bobes C; Ronzón-Fernández A; Castaño-Fernández G; Botas-Cervero P
    Neurocirugia (Astur); 2006 Dec; 17(6):538-41. PubMed ID: 17242842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Male prolactin producing pituitary microadenoma -a case report (author's transl)].
    Teramoto A; Takakura K; Sano K; Fukushima T; Ishibashi M; Yamaji T
    No Shinkei Geka; 1982 Feb; 10(2):185-90. PubMed ID: 7063099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperprolactinaemia in patients with pituitary adenomas. The pituitary stalk compression syndrome.
    Kruse A; Astrup J; Gyldensted C; Cold GE
    Br J Neurosurg; 1995; 9(4):453-7. PubMed ID: 7576271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonfunctional pituitary macroadenoma manifested as muscular symptoms.
    Matsubara A; Tamura A; Matsumura S; Yokoya H; Maruyama S; Kobayashi K; Kawamoto Y; Teishima J; Seki M; Usui T
    Hiroshima J Med Sci; 2006 Dec; 55(4):117-20. PubMed ID: 17274542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinaemia and hypogonadism in men: response to exogenous gonadotrophins.
    Luboshitzky R; Rosen E; Trestian S; Spitz IM
    Clin Endocrinol (Oxf); 1979; 11(2):217-23. PubMed ID: 487619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic-induced hyperprolactinaemia.
    Inder WJ; Castle D
    Aust N Z J Psychiatry; 2011 Oct; 45(10):830-7. PubMed ID: 21714721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
    Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
    Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy].
    Riecher-Rössler A; Schmid C; Bleuer S; Birkhäuser M
    Neuropsychiatr; 2009; 23(2):71-83. PubMed ID: 19573500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic changes of prolactin-producing pituitary adenomas after short treatment with dopamine agonists.
    Kontogeorgos G; Horvath E; Kovacs K; Coire C; Lloyd RV; Scheithauer BW; Smyth HS
    Acta Neuropathol; 2006 Jan; 111(1):46-52. PubMed ID: 16328513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men.
    Bloch M; Rubinow DR; Berlin K; Kevala KR; Kim HY; Schmidt PJ
    Arch Gen Psychiatry; 2006 Apr; 63(4):450-6. PubMed ID: 16585475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole.
    Rhoden EL; Morgentaler A
    Int J Impot Res; 2004 Feb; 16(1):95-7. PubMed ID: 14963480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful gonadotrophin treatment of hypogonadism in postoperative patients with macroprolactinoma and persistent hyperprolactinaemia.
    Isurugi K; Kajiwara T; Hosaka Y; Minowada S
    Int J Androl; 1993 Oct; 16(5):306-10. PubMed ID: 8276523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.